Cargando…

Targeting FGF21 in cardiovascular and metabolic diseases: from mechanism to medicine

Cardiovascular and metabolic disease (CVMD) is becoming increasingly prevalent in developed and developing countries with high morbidity and mortality. In recent years, fibroblast growth factor 21 (FGF21) has attracted intensive research interest due to its purported role as a potential biomarker an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Huiling, Yue, Tong, Chen, Zhengfang, Wu, Weiming, Xu, Suowen, Weng, Jianping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760446/ https://www.ncbi.nlm.nih.gov/pubmed/36594101 http://dx.doi.org/10.7150/ijbs.73936

Ejemplares similares

Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies
por: Wu, Xiumei, et al.
Publicado: (2023)

Serum Metabolomic Profiling in Aging Mice Using Liquid Chromatography—Mass Spectrometry
por: Yue, Tong, et al.
Publicado: (2022)

Resveratrol in Treating Diabetes and Its Cardiovascular Complications: A Review of Its Mechanisms of Action
por: Su, Meiming, et al.
Publicado: (2022)

Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases
por: Cheng, Peng, et al.
Publicado: (2016)

The role of FGF21 in the pathogenesis of cardiovascular disease
por: Zhang, Ying, et al.
Publicado: (2021)

CREBH Improves Diet-Induced Obesity, Insulin Resistance, and Metabolic Disturbances by FGF21-Dependent and FGF21-Independent Mechanisms
por: Satoh, Aoi, et al.
Publicado: (2020)

ASGR1: an emerging therapeutic target in hypercholesterolemia
por: Zhao, Wenqi, et al.
Publicado: (2023)

GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
por: Ma, Xiaoxuan, et al.
Publicado: (2021)

Inventing new medicines: The FGF21 story()
por: Kharitonenkov, Alexei, et al.
Publicado: (2013)

FGF21 as a Stress Hormone: The Roles of FGF21 in Stress Adaptation and the Treatment of Metabolic Diseases
por: Kim, Kook Hwan, et al.
Publicado: (2014)

Decreased FGF19 and FGF21: possible underlying common pathogenic mechanism of metabolic and cognitive dysregulation in depression
por: Tang, Mimi, et al.
Publicado: (2023)

Hepatic FGF21: Its Emerging Role in Inter-Organ Crosstalk and Cancers
por: SUI, Yue, et al.
Publicado: (2022)

Metabolic Effects of FGF-21: Thermoregulation and Beyond
por: Ni, Bin, et al.
Publicado: (2015)

FGF21 as Modulator of Metabolism in Health and Disease
por: Tezze, Caterina, et al.
Publicado: (2019)

FGF19 subfamily members: FGF19 and FGF21
por: Dolegowska, Katarzyna, et al.
Publicado: (2019)

Analysis of Functional Promoter of Camel FGF21 Gene and Identification of Small Compounds Targeting FGF21 Protein
por: Yong, Fang, et al.
Publicado: (2023)

Fibroblast Growth Factor 21 (FGF21) in Human Cerebrospinal Fluid: Relationship With Plasma FGF21 and Body Adiposity
por: Tan, Bee K., et al.
Publicado: (2011)

Localization of FGF21 Protein and Lipid Metabolism-Related Genes in Camels
por: Gao, Yuan, et al.
Publicado: (2023)

Targeting inflammation and cytokine storm in COVID-19
por: Huang, Qianwen, et al.
Publicado: (2020)

FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases
por: Tillman, Erik J., et al.
Publicado: (2020)

Hyperglycemia‐mediated oocyte TET3 insufficiency predisposes offspring to glucose intolerance
por: Wu, Xiumei, et al.
Publicado: (2022)

Lower Cerebrospinal Fluid/Plasma Fibroblast Growth Factor 21 (FGF21) Ratios and Placental FGF21 Production in Gestational Diabetes
por: Tan, Bee K., et al.
Publicado: (2013)

FGF19 and FGF21: In NASH we trust
por: Talukdar, Saswata, et al.
Publicado: (2020)

FGF21 as a Hepatokine, Adipokine, and Myokine in Metabolism and Diseases
por: Itoh, Nobuyuki
Publicado: (2014)

Central FGF21 production regulates memory but not peripheral metabolism
por: Zhou, Bolu, et al.
Publicado: (2022)

The potential function and clinical application of FGF21 in metabolic diseases
por: Chen, Zhiwei, et al.
Publicado: (2022)

FGF21 and Cardiac Physiopathology
por: Planavila, Anna, et al.
Publicado: (2015)

Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo
por: Adams, Andrew C., et al.
Publicado: (2012)

Hepatic FGF21 preserves thermoregulation and cardiovascular function during bacterial inflammation
por: Huen, Sarah C., et al.
Publicado: (2021)

FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human
por: Henriksson, Emma, et al.
Publicado: (2020)

Aging is associated with increased FGF21 levels but unaltered FGF21 responsiveness in adipose tissue
por: Villarroya, Joan, et al.
Publicado: (2018)

COVID-19 and Kawasaki disease in children
por: Xu, Suowen, et al.
Publicado: (2020)

A bibliometric study of COVID-19 research in Web of Science
por: Su, Meiming, et al.
Publicado: (2021)

Endothelial Cells as a Key Cell Type for Innate Immunity: A Focused Review on RIG-I Signaling Pathway
por: Xu, Suowen, et al.
Publicado: (2022)

FGF21 Promotes Metabolic Homeostasis via White Adipose and Leptin in Mice
por: Véniant, Murielle M., et al.
Publicado: (2012)

The role of FGF21 in type 1 diabetes and its complications
por: Zhang, Jian, et al.
Publicado: (2018)

FGF21 regulates circadian behavior and metabolism by acting on the nervous system
por: Bookout, Angie L., et al.
Publicado: (2013)

FGF21 regulates hepatic metabolic pathways to improve steatosis and inflammation
por: Keinicke, Helle, et al.
Publicado: (2020)

Genome-Wide Transcriptional Profiling Reveals PHACTR1 as a Novel Molecular Target of Resveratrol in Endothelial Homeostasis
por: Su, Meiming, et al.
Publicado: (2022)

Fibroblast Growth Factor 21 (FGF-21) in Peritoneal Dialysis Patients: Natural History and Metabolic Implications
por: González, Elena, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f41jkhpukvekk778435uqk26l5